Stock Events

Stock Events

Viveon Health Acquisition 

$10
1
+$0+0% Wednesday 20:00

Statistics

Day High
11
Day Low
10
52W High
11.9
52W Low
0
Volume
1
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

21NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.24
-0.11
0.01
0.14
Expected EPS
N/A
Actual EPS
-0.24

Financials

-Profit Margin
Unprofitable
2020
2021
2022
0Revenue
-487,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VHAQ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Jazz Pharmaceuticals
JAZZ
Mkt Cap8.35B
Jazz Pharmaceuticals focuses on identifying, developing, and commercializing pharmaceutical products, which directly competes with Viveon Health's strategy in the healthcare sector.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation which competes in developing and marketing drugs and vaccines, overlapping with Viveon Health's market.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, competing with Viveon Health.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a multinational corporation that produces medical devices, pharmaceutical, and consumer packaged goods, directly competing across multiple segments with Viveon Health.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceuticals industry, focusing on immunology, oncology, neuroscience, and virology, areas that Viveon Health may also target.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biopharmaceutical company that discovers, develops, manufactures, and delivers human therapeutics, competing in the biotech and healthcare space with Viveon Health.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, competing with Viveon Health's objectives.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas such as HIV/AIDS, liver diseases, hematology/oncology, which may overlap with Viveon Health's focus areas.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing in pharmaceuticals and healthcare services.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a broad range of products in oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation, competing in similar fields as Viveon Health.

About

Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia.
Show more...
CEO
Dr. Jagi Gill M.D., Ph.D.
Country
US
ISIN
US92853V1061

Listings

0 Comments

Share your thoughts

FAQ

What is Viveon Health Acquisition stock price today?▼
The current price of VHAQ is $10 USD — it has increased by +0% in the past 24 hours. Watch Viveon Health Acquisition stock price performance more closely on the chart.
What is Viveon Health Acquisition stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Viveon Health Acquisition stocks are traded under the ticker VHAQ.
What were Viveon Health Acquisition earnings last quarter?▼
VHAQ earnings for the last quarter are -0.24 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Viveon Health Acquisition revenue for the last year?▼
Viveon Health Acquisition revenue for the last year amounts to 0 USD.
What is Viveon Health Acquisition net income for the last year?▼
VHAQ net income for the last year is -487,000 USD.
In which sector is Viveon Health Acquisition located?▼
Viveon Health Acquisition operates in the Financials sector.
When did Viveon Health Acquisition complete a stock split?▼
Viveon Health Acquisition has not had any recent stock splits.
Where is Viveon Health Acquisition headquartered?▼
Viveon Health Acquisition is headquartered in Atlanta, US.